The endocannabinoid system (ECS) is one of the most fascinating discoveries in modern biology. It regulates functions as important as pain, stress, sleep, appetite and mood. Although for years it went unnoticed, today we know that it plays an essential role in daily health and well-being.
The SEC acts as a regulatory system that helps the organism adapt to changes in the environment and maintain internal stability, a process known as homeostasis.
In this article we explain in a clear and accessible way what the endocannabinoid system is, how it works in the human body and why it is so relevant to understand how certain habits and natural compounds, such as those present in CBD oils, influence our wellness routines.
The endocannabinoid system regulates your wellbeing every day
The endocannabinoid system is constantly active, even if you are not aware of it. It is involved in everyday processes such as:
- Perception of pain and physical discomfort
- Stress response and mood
- Quality of sleep and rest
- Hunger sensation and digestion
- The balance of the immune system
When this system functions correctly, the body is able to maintain a state of equilibrium. On the contrary, if it is disturbed, imbalances may appear that affect the general well-being.
What is the endocannabinoid system?
The endocannabinoid system is a biological cell signaling network distributed throughout the body. It was discovered in the 1990s (1), while scientists were studying how cannabis compounds affect the brain.
Since then, research has shown that the endocannabinoid system is not dependent on cannabis use, but is a natural part of our body. It plays key roles in the regulation of multiple physiological processes.
SEC regulates pain, stress, sleep, and appetite.
SEC acts as a universal regulator of the body and is involved in numerous key physiological processes:
- Pain regulation: modulates pain perception at the nervous system level (2).
- Stress and mood: influences emotional response and sense of well-being (7).
- Sleep and rest: it participates in the regulation of sleep cycles and circadian rhythm (8).
- Appetite and metabolism: it regulates the sensation of hunger and influences energy metabolism (6).
- Memory and learning: modulates communication between neurons, favoring brain plasticity (9).
- Immune response: helps control inflammation (10).
In other words, the endocannabinoid system is a major regulator of the body that is always active in maintaining health and internal balance.
How does the endocannabinoid system work?
The three components of the endocannabinoid system
The endocannabinoid system is made up of three main components:
- Endocannabinoids: these are molecules produced by the body itself that structurally resemble the cannabinoids of the cannabis plant (2). The best known are anandamide (AEA) and 2-arachidonylglycerol (2-AG).
- Cannabinoid receptors: these are proteins located on the surface of cells, mainly CB1 and CB2 receptors, which receive signals from endocannabinoids (3).
- Endocannabinoid enzymes: these are responsible for synthesizing and degrading endocannabinoids when they have already fulfilled their function in the body (4), such as FAAH and MAGL.
Together, these elements work in coordination to maintain the internal balance of the organism, a principle known as homeostasis (5).
CB1 and CB2 cannabinoid receptors: how they act in the body

Cannabinoid receptors are the junction point between endocannabinoids and the cells of the body:
- CB1: they are mainly located in the brain and central nervous system. They regulate functions such as movement, memory, appetite or mood (11).
- CB2: found mainly in the immune system and peripheral tissues. Their main function is to control inflammation and immune responses (10).
These receptors are essential for endocannabinoids to exert their effect. When the body produces anandamide or 2-AG, these molecules couple to CB1 or CB2 receptors, activating specific responses that help maintain body balance.
Anandamide and 2-AG: the natural messengers of the SEC

Endocannabinoids are the natural messengers of the system:
- Anandamide (AEA): its name comes from the Sanskrit ananda, meaning “happiness”. It is related to the sensation of pleasure, relaxation and emotional well-being (2).
- 2-arachidonylglycerol (2-AG): involved in the regulation of the immune system, inflammation and neuroprotection (12).
Both are lipid molecules produced on demand. That is, the body does not store them, but synthesizes them when it needs them. This allows a rapid response to situations of stress, pain or internal imbalance (2).
Enzymes that regulate the duration of effects

Enzymes of the endocannabinoid system control how long the effects of endocannabinoids last. The most important ones are:
- FAAH (fatty acid amide hydrolase): degrades anandamide once it has fulfilled its function (4).
- MAGL (monoacylglycerol lipase): responsible for breaking down 2-AG.
Thanks to these enzymes, the system can respond with precision. This fine regulation explains why the SEC is involved in processes as diverse as memory, appetite and pain response.
An unbalanced SEC can affect your health
When the SEC functions correctly, the organism maintains a state of equilibrium. But if it is disturbed, dysfunctions associated with:
- Mood disorders such as anxiety or depression (7).
- Chronic inflammatory and neuropathic pain (13).
- Metabolic problems such as obesity (14).
- Sleep disorders (8).
- Persistent inflammations (13).
Some studies suggest that an imbalance of the endocannabinoid system, also called “clinical endocannabinoid deficiency”, could be behind multiple diseases (16). This is why research is being done on how natural compounds such as CBD oil or aromatic products such as CBD flowers can help regulate it safely.
SEC maintains homeostasis: the balance your body needs.
The term homeostasis refers to the body’s ability to maintain stable internal conditions even when the environment changes (5). The endocannabinoid system plays a key role in this function.
It acts as a sensor that detects imbalances and sends “corrective” signals to different organs and tissues (16). For example, if the body experiences excess inflammation, the SEC can release endocannabinoids to reduce it (17).
If there is neuronal overexcitation, the system acts by decreasing the activity of the neurons involved (18). This self-regulatory capacity makes the endocannabinoid system an essential pillar of human health (19).

The endocannabinoid system also regulates appetite and metabolism.
One of the most studied fields is the relationship between the endocannabinoid system, metabolism and appetite (5). CB1 receptors present in the hypothalamus influence the sensation of hunger and fat storage (6).
In fact, some drugs designed to block CB1 have been tested as anti-obesity treatments (14). On the other hand, endocannabinoids also act on energy metabolism (19), helping to balance caloric expenditure and nutrient absorption.
SEC protects and regulates your digestive system.
The gastrointestinal tract is full of CB1 and CB2 receptors, demonstrating the importance of the SEC in digestion. This system regulates intestinal motility, gastric secretion and the immune response of the intestine (20).
Therefore, the study of the endocannabinoid system in the gastrointestinal tract has gained relevance for the treatment of diseases such as irritable bowel syndrome (IBS) or Crohn’s disease (21).
Taking care of your endocannabinoid system is taking care of your well-being.
The endocannabinoid system is a vital network that connects body and mind, regulating functions essential for health and balance. Science has demonstrated its relevance in modulating pain, mood, metabolism and immune response, although much research remains to be done.
Knowing and taking care of this system through good habits, and even natural cannabinoids such as CBD, can be key to improving our overall well-being. However, any use for therapeutic purposes should be under professional guidance, as European regulations vary and scientific evidence is still developing.
Frequently asked questions about the endocannabinoid system
How does the endocannabinoid system work in the body?
The endocannabinoid system (ECS) is a biological network present in all vertebrates. Its function is to maintain the internal balance of the organism (homeostasis) by means of molecules called endocannabinoids, cell receptors CB1 and CB2, and enzymes in charge of their degradation.
The SEC works through the interaction between:
- Endocannabinoids: natural substances produced by the body.
- CB1 and CB2 receptors: located in the brain, nervous system, immune system and other tissues.
- Enzymes that regulate their quantity.
What is the endocannabinoid system for?
The endocannabinoid system is key to:
- Regulating mood and stress response
- Control pain and inflammation
- Appetite and satiety management
- Balance the sleep-wake cycle.
- Support immune function
- Modulating memory and learning
Because of its role in so many processes, it is considered an essential system for physical health and general well-being.
What is the difference between endocannabinoids and phytocannabinoids?
Endocannabinoids are substances produced by the human body itself, such as anandamide and 2-AG, which are responsible for activating SEC receptors.
Phytocannabinoids, such as CBD or THC, come from plants (mainly cannabis) and can also interact with the SEC, although they do so in different ways. For example, CBD does not bind directly to CB1 and CB2 receptors, but acts by modulating their activity and promoting the overall balance of the system.
How can I maintain or improve the endocannabinoid system naturally?
The SEC responds positively to healthy habits. To promote its functioning it is recommended:
- Diet rich in omega-3 (oily fish, chia seeds, walnuts)
- Moderate and constant exercise
- Adequate sleep
- Avoid chronic stress through techniques such as meditation or breathing.
- Moderate sun exposure
- Healthy social life
- Cannabidiol-rich cannabis oils
These factors help the body produce and use endocannabinoids more efficiently.
What is the relationship between the endocannabinoid system and CBD?
CBD (cannabidiol) and other cannabinoids can influence the endocannabinoid system, helping to modulate processes such as inflammation, stress or pain perception. Unlike THC, CBD does not produce psychoactive effects, which has generated growing interest in Europe and Spain.
The objective of this article is informative and seeks to provide scientific information in a language understandable to the general public. Its content can complement, but never replace, the diagnosis or treatment of any disease or symptom.
Cannactiva’s CBD products are intended for external use.
- Pertwee R. G. (2006). Cannabinoid pharmacology: the first 66 years. British journal of pharmacology, 147 Suppl 1(Suppl 1), S163-S171. https://doi.org/10.1038/sj.bjp.0706406
- Pete, D.D., Narouze, S.N. (2021). Endocannabinoids: Anandamide and 2-Arachidonoylglycerol (2-AG). In: Narouze, S.N. (eds) Cannabinoids and Pain. Springer, Cham. https://doi.org/10.1007/978-3-030-69186-8_9
- Howlett, A. C., & Abood, M. E. (2017). CB1 and CB2 Receptor Pharmacology. Advances in pharmacology (San Diego, Calif.), 80, 169-206. https://doi.org/10.1016/bs.apha.2017.03.007
- Di Marzo, V., De Petrocellis, L., Bisogno, T., & Melck, D. (1999). Metabolism of anandamide and 2-arachidonoylglycerol: an historical overview and some recent developments. Lipids, 34 Suppl, S319-S325. https://doi.org/10.1007/BF02562332
- Filho, Ronaldo & Marchiori, Carlos & Malheiros, Klebert. (2024). Relationship of the Endocannabinoid System with Hormonal Functions. Middle East Research Journal of Medical Sciences. 4. 245-260. https://doi.org/10.36348/merjms.2024.v04i06.012
- Jager, G., & Witkamp, R. F. (2014). The endocannabinoid system and appetite: relevance for food reward. Nutrition research reviews, 27(1), 172-185. https://doi.org/10.1017/S0954422414000080
- Ashton, C. H., & Moore, P. B. (2011). Endocannabinoid system dysfunction in mood and related disorders. Acta psychiatrica Scandinavica, 124(4), 250-261. https://doi.org/10.1111/j.1600-0447.2011.01687.x
- Camberos-Barraza, J., et al. (2024). Sleep, Glial Function, and the Endocannabinoid System: Implications for Neuroinflammation and Sleep Disorders. International journal of molecular sciences, 25(6), 3160. https://doi.org/10.3390/ijms25063160
- Zhang, J., et al. (2020). The Endocannabinoid System Contributes to Memory Deficits Induced by Rapid-eye-movement Sleep Deprivation in Adolescent Mice. Neuroscience, 433, 174-183. https://doi.org/10.1016/j.neuroscience.2020.03.016
- Svízenská, I., Dubový, P., & Sulcová, A. (2008). Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures–a short review. Pharmacology, biochemistry, and behavior, 90(4), 501-511. https://doi.org/10.1016/j.pbb.2008.05.010
- Callén, L., et al. (2012). Cannabinoid receptors CB1 and CB2 form functional heteromers in brain. The Journal of biological chemistry, 287(25), 20851-20865. https://doi.org/10.1074/jbc.M111.335273. https://doi.org/10.1074/jbc.M111.335273
- Sugiura, T., et al. (2006). Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Progress in lipid research, 45(5), 405-446. https://doi.org/10.1016/j.plipres.2006.03.003
- Donvito, G., et al. (2018). The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain. Neuropsychopharmacology, 43(1), 52-79. https://doi.org/10.1038/npp.2017.204
- Rakotoarivelo, V., Sihag, J., & Flamand, N. (2021). Role of the Endocannabinoid System in the Adipose Tissue with Focus on Energy Metabolism. Cells, 10(6), 1279 . https://doi.org/10.3390/cells10061279.
- Russo E. B. (2016). Clinical Endocannabinoid Deficiency Reconsidered. Cannabis and cannabinoid research, 1(1), 154-165. https://doi.org/10.1089/can.2016.0009
- Roche, R., et al. (2006). Presence of the cannabinoid receptors, CB1 and CB2, in human adipocytes. https://doi.org/10.1007/s00418-005-0127-4
- Clayton, N., et al. (2002). CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain. https://doi.org/10.1016/S0304-3959(01)00454-7
- Rathod, S. S., et al. (2023). Neuroinflammation in the CNS. https://doi.org/10.3390/biomedicines11102642
- Freitas, H. R., et al. (2018). Polyunsaturated fatty acids and endocannabinoids. https://doi.org/10.1080/1028415X.2017.1347373
- Smid S. D. (2008). Gastrointestinal endocannabinoid system. https://doi.org/10.1111/j.1440-1681.2008.05016.x
- Bochenek, M. S., et al. (2024). Endogenous Cannabinoids in Crohn’s Disease. https://doi.org/10.3390/app14156646